Oral Antiviral Demonstrates Prevention of COVID-19 in Phase 3 Study
Ensitrelvir demonstrated a 67% relative risk reduction of developing symptomatic COVID-19 in household contact patients.
Dispensing Leadership: Defining Your Philosophy
Join Shawn Bjorndal, PharmD, RPh, and Jesse McCullough, PharmD, for the first episode of Dispensing Leadership, a new podcast from Drug Topics® and RPhAlly.
Baricitinib Shows Significant Hair Regrowth for Pediatric Patients With Alopecia Areata
Patients aged 12 to under 18 saw clinically meaningful regrowth on the scalp, eyebrow, and eyelashes with both high-dose and low-dose treatment.
How Barbershops Are Becoming Community Health Care Destinations
The Cut Hypertension Program operates in barbershops across the Bay Area in California. The program’s lead pharmacist joined us to discuss main themes and goals of the new initiative.
CagriSema Demonstrates Significant Weight Loss at 68 Weeks
Approximately 89.7% of patients taking CagriSema achieve the coprimary end point of weight loss of 5% or more compared with 30.3% on the placebo.
Bleeding Disorders Significantly Impact Quality of Life Among Women
Researchers analyzed historical characteristics of bleeding disorders among women by highlighting clinical challenges and management strategies.
